Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brandon Diaz

Vascular Surgery Miami, FL Medical Doctor

NPI 1740631571 CMS profile 4225345

11760 Sw 40Th St Ste 301, Miami, FL 33175

Open in the dashboard

General payments

$20,490

204 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brandon Diaz of Miami, FL is reported in the CMS Open Payments database as having received $20,490 across 204 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,015 122
2024 General $3,770 35
2023 General $2,140 18
2022 General $1,494 17
2021 General $889 10
2019 General $183 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brandon Diaz
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Brandon Diaz were reported at $12,015. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Brandon Diaz Vascular Surgery median Middle half National median
2019 $183 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $889 $471 $158–$1,421 $132
2022 $1,494 $725 $222–$2,183 $149
2023 $2,140 $836 $257–$2,440 $160
2024 $3,770 $909 $252–$2,619 $164
2025 $12,015 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $7,400 66 payments
  2. Penumbra, Inc. $4,385 21 payments
  3. Boston Scientific Corporation $954 8 payments
  4. Asahi Intecc USA, Inc. $884 15 payments
  5. Bard Peripheral Vascular, Inc. $869 8 payments
  6. Endologix, Inc. $766 6 payments
  7. Silk Road Medical, Inc. $605 5 payments
  8. Shockwave Medical, Inc $531 5 payments
  9. Cardiva Medical, Inc. $517 11 payments
  10. Philips Electronics North America Corporation $444 7 payments
  11. Other $3,135 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $15,258 188 payments
  2. Travel and Lodging $2,241 9 payments
  3. Grant $1,500 1 payment
  4. Education $1,491 6 payments
Products named General payments · program years 2019–2025
  1. ENDURANT IIS $2,428 32 payments
  2. Indigo System $2,161 13 payments
  3. RUBY Coil $1,466 3 payments
  4. Asahi Peripheral Vascular Wires $884 15 payments
  5. Valiant Captivia $703 6 payments
  6. Penumbra System $620 4 payments
  7. Alto Abdominal Stent Graft System $613 5 payments
  8. ENROUTE Transcarotid Stent $605 5 payments
  9. ENROUTE Transcarotid Neuroprotection System $605 5 payments
  10. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $531 5 payments
  11. Other $9,864 147 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

204 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record